Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nesrina Imami

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Plos One|May 13, 2009
Transient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllersSamantha J Westrop, Nadeem A Qazi, Jeffrey Pido-Lopez, et al.
AIDS Research and Human Retroviruses|March 18, 2003
Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune)Jeffrey Pido-Lopez, Catherine Burton, Gareth Hardy, et al.
Frontiers in Immunology|March 3, 2020
Pregnancy Gestation Impacts on HIV-1-Specific Granzyme B Response and Central Memory CD4 T CellsAlexander T H Cocker, Nishel M Shah, Inez Raj, et al.
AIDS Research and Human Retroviruses|March 6, 2004
HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative UgandansAnthony Kebba, Pontiano Kaleebu, Jennifer Serwanga, et al.
Vaccine|December 3, 2014
Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infectionAnna Herasimtschuk, Jocelyn Downey, Mark Nelson, et al.
AIDS (London, England)|October 18, 2005
Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapyChristopher M Mela, Catherine T Burton, Nesrina Imami, et al.
AIDS (London, England)|June 12, 2003
Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infectionJohn F Morlese, Chloë M Orkin, Riaz Abbas, et al.
AIDS Research and Human Retroviruses|August 17, 2004
HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected UgandansAlleluiah Rutebemberwa, Betty Auma, Jill Gilmour, et al.
Journal of Immune Based Therapies and Vaccines|April 13, 2007
A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapyGareth Ad Hardy, Nesrina Imami, Mark R Nelson, et al.
Rejuvenation Research|March 24, 2007
Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccinationRichard Aspinall, Jeffrey Pido-Lopez, Nesrina Imami, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Plos One|May 13, 2009
Transient nature of long-term nonprogression and broad virus-specific proliferative T-cell responses with sustained thymic output in HIV-1 controllersSamantha J Westrop, Nadeem A Qazi, Jeffrey Pido-Lopez, et al.
AIDS Research and Human Retroviruses|March 18, 2003
Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune)Jeffrey Pido-Lopez, Catherine Burton, Gareth Hardy, et al.
Frontiers in Immunology|March 3, 2020
Pregnancy Gestation Impacts on HIV-1-Specific Granzyme B Response and Central Memory CD4 T CellsAlexander T H Cocker, Nishel M Shah, Inez Raj, et al.
AIDS Research and Human Retroviruses|March 6, 2004
HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative UgandansAnthony Kebba, Pontiano Kaleebu, Jennifer Serwanga, et al.
Vaccine|December 3, 2014
Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infectionAnna Herasimtschuk, Jocelyn Downey, Mark Nelson, et al.
AIDS (London, England)|October 18, 2005
Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapyChristopher M Mela, Catherine T Burton, Nesrina Imami, et al.
AIDS (London, England)|June 12, 2003
Plasma IL-6 as a marker of mycobacterial immune restoration disease in HIV-1 infectionJohn F Morlese, Chloë M Orkin, Riaz Abbas, et al.
AIDS Research and Human Retroviruses|August 17, 2004
HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected UgandansAlleluiah Rutebemberwa, Betty Auma, Jill Gilmour, et al.
Journal of Immune Based Therapies and Vaccines|April 13, 2007
A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapyGareth Ad Hardy, Nesrina Imami, Mark R Nelson, et al.
Rejuvenation Research|March 24, 2007
Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccinationRichard Aspinall, Jeffrey Pido-Lopez, Nesrina Imami, et al.
Pageof 6